Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Teleflex Gets FDA 510(k) Clearance To Market Pressure Injectable ARROW PICC

RELATED NEWS
Trade TFX now with 

Teleflex Incorporated (TFX: Quote), a global provider of medical devices for critical care and surgery, announced it has received FDA 510(k) clearance to market its pressure injectable ARROW PICC preloaded with the ARROW VPS Vascular Positioning System Stylet. The ARROW VPS replaces the need for confirmatory chest X-ray in the presence of a stable Blue Bullseye by using real-time intravascular Doppler, ECG and advanced algorithmic logic to notify the clinician that the catheter tip has reached the optimal location. The preloaded option improves clinician ease of use for vascular navigation and catheter tip positioning.

From a workflow perspective, the preloaded ARROW PICC benefits clinicians by saving the time and process of loading the ARROW VPS Stylet into the catheter. Clinically, the ARROW VPS confirms accurate catheter tip position in the lower 1/3 of the SVC-Cavo-Atrial Junction, which has been proven to reduce complications such as thrombosis.

Click here to receive FREE breaking news email alerts for Teleflex Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.